Goldman Sachs’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $779K | Sell |
|
|||||
|
2025
Q1 | $954K | Buy |
|
|||||
|
2024
Q4 | $747K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.24M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $860K | Buy |
|
|||||
|
2023
Q1 | $460K | Sell |
|
|||||
|
2022
Q4 | $523K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $127K | Sell |
|
|||||
|
2021
Q2 | $515K | Buy |
|
|||||
|
2021
Q1 | $252K | Buy |
|
|||||
|
2020
Q4 | $77K | Sell |
|
|||||
|
2020
Q3 | $239K | Buy |
|
|||||
|
2020
Q2 | $652K | Sell |
|
|||||
|
2020
Q1 | $649K | Buy |
|
|||||
|
2019
Q4 | $911K | Buy |
|
|||||
|
2019
Q3 | $556K | Buy |
|
|||||
|
2019
Q2 | $369K | Buy |
|
|||||
|
2019
Q1 | $392K | Buy |
|
|||||
|
2018
Q4 | $304K | Sell |
|
|||||
|
2018
Q3 | $692K | Buy |
|
|||||
|
2018
Q2 | $260K | Sell |
|
|||||
|
2018
Q1 | $815K | Sell |
|
|||||
|
2017
Q4 | $1.37M | Sell |
|
|||||
|
2017
Q3 | $2.45M | Buy |
|
|||||
|
2017
Q2 | $68K | Sell |
|
|||||
|
2017
Q1 | $580K | Buy |
|
|||||
|
2016
Q4 | $58K | Sell |
|
|||||
|
2016
Q3 | $411K | Buy |
|
|||||
|
2016
Q2 | $41K | Buy |
|
|||||
|
2016
Q1 | $31K | Sell |
|
|||||
|
2015
Q4 | $75K | Buy |
|